Malignant T Cell Amplified Sequence 1 (MCTS1) Peptide
-
- Target See all MCTS1 products
- MCTS1 (Malignant T Cell Amplified Sequence 1 (MCTS1))
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunogen (Imm)
- Sequence
- DEKENVSNCI QLKTS
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Storage
- -20 °C
- Storage Comment
- Shipped at ambient temperature, store at -20°C.
-
- Target
- MCTS1 (Malignant T Cell Amplified Sequence 1 (MCTS1))
- Synonyms
- MCT-1 Peptide, MCT1 Peptide, MCT1a Peptide, cb517 Peptide, zgc:55682 Peptide, 1500019M23Rik Peptide, zgc:56242 Peptide, mcts1 Peptide, MGC89874 Peptide, MCTS1 Peptide, MCT-1A Peptide, mct-1 Peptide, mct1 Peptide, MCT-1B Peptide, mcts1-a Peptide, mcts1-b Peptide, MCTS1, re-initiation and release factor Peptide, solute carrier family 16 (monocarboxylate transporter), member 1b Peptide, malignant T cell amplified sequence 1 Peptide, malignant T-cell amplified sequence 1 Peptide, solute carrier family 16 member 1 Peptide, malignant T-cell amplified sequence 1 S homeolog Peptide, monocarboxylate transporter 1 Peptide, malignant T-cell amplified sequence 1 L homeolog Peptide, MCTS1 Peptide, slc16a1b Peptide, Mcts1 Peptide, mcts1 Peptide, SLC16A1 Peptide, mcts1.S Peptide, MCT1 Peptide, mcts1.L Peptide
-